Company Filing History:
Years Active: 2003-2010
Title: Richard Sharp: Innovator in Bacteriophage Research
Introduction
Richard Sharp is a notable inventor based in Salisbury, GB. He has made significant contributions to the field of bacteriophage research, holding a total of 2 patents. His work focuses on innovative solutions for treating bacterial infections, particularly those associated with biofilms and intracellular infections.
Latest Patents
One of Richard Sharp's latest patents is centered on a composition for treating bacterial biofilms. This invention includes a first bacteriophage capable of infecting bacteria within the biofilm, along with a first polysaccharide lyase enzyme that degrades polysaccharides in the biofilm. The composition may also contain a pharmaceutically acceptable antimicrobial agent and potentially a DNase. Additionally, he has developed methods for creating modified bacteriophages and their use in treating biofilms.
Another significant patent addresses the treatment of intracellular infections. This invention comprises an agent that includes a phage component and a targeting moiety that directs the agent to a target cell. Once inside the target cell, the phage initiates lysis of the microorganism residing within. A mycobacteriophage is combined with a targeting moiety of transferrin, enhancing the effectiveness of the treatment.
Career Highlights
Richard Sharp has worked with several organizations, including Biocontrol Limited and the Health Protection Agency. His experience in these companies has contributed to his expertise in bacteriophage research and development.
Collaborations
Throughout his career, Richard has collaborated with notable individuals such as Gavin Hughes and James Taggart Walker. These partnerships have likely enriched his research and innovation efforts.
Conclusion
Richard Sharp is a pioneering inventor whose work in bacteriophage research has the potential to revolutionize the treatment of bacterial infections. His innovative patents and collaborations highlight his commitment to advancing medical science.